Skip to main
WAT

Waters (WAT) Stock Forecast & Price Target

Waters (WAT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 28%
Hold 44%
Sell 0%
Strong Sell 0%

Bulls say

Waters is well-positioned to benefit from improving demand in pharma manufacturing, with a strong track record of turning around underperforming businesses and successfully integrating large acquisitions. The recent merger with BD's life science and diagnostics business should bring significant growth and cost synergies, as well as expanding Waters' reach into the diagnostics and discovery-related life science tools market. Additionally, the company has a strong management team with a track record of successful turnarounds and acquisitions.

Bears say

Waters is facing multiple challenges that could negatively impact its growth potential and financial performance in the near future. The company's recent merger with BD's life science and diagnostics business has increased its exposure to diagnostics, which has been facing weakening industry trends. This increased concentration may dilute Waters' organic sales growth potential and also divert management's time and resources, hindering its ability to effectively address these challenges. Additionally, the company's high-margin consumables and service contracts may not be enough to sustain its resilient recurring revenue base if the demand for its products continues to decline in the academic and government markets.

Waters (WAT) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 28% recommend Buy, 44% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Waters and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Waters (WAT) Forecast

Analysts have given Waters (WAT) a Buy based on their latest research and market trends.

According to 18 analysts, Waters (WAT) has a Buy consensus rating as of Jul 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $400, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $400, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Waters (WAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.